Diadem
Blood-based test utilizing a unique antibody to target a specific p53 protein shape for medical analysis.
2
Funding Rounds
$22.0m
Money raised
Overview
Blood-based test utilizing a unique antibody to target a specific p53 protein shape for medical analysis.
- Website:
- Business model: B2B
- Headquarters: Brescia
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Diadem has raised a total of $22m in funding over 2 rounds.
Key Insights:
- Diadem , March 2022: $11m
- Diadem March 2022 Funding Round: $11m
Diadem , March 2022
$11m
Diadem March 2022 Funding Round
$11m
Industries
Diadem is active in the following industries: